
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
UCK1 CRISPR/Cas9 KO Plasmid (m) | sc-423608 | 20 µg | $397.00 |
Uck1 encodes uridine-cytidine kinase 1 (UCK1), a cytosolic salvage-pathway enzyme that phosphorylates uridine and cytidine to UMP and CMP, supplying pyrimidine nucleotides for RNA synthesis, DNA replication, and membrane phospholipid metabolism. By regulating nucleotide pool balance, UCK1 influences proliferative capacity, cell-cycle progression, and stress responses linked to replication and transcriptional demand. In mouse systems, UCK1 activity is commonly examined alongside de novo pyrimidine synthesis and nucleoside transport to understand metabolic rewiring and compensatory flux within nucleotide homeostasis. Altered pyrimidine metabolism is a recurring feature of disorders involving dysregulated proliferation and genome maintenance, making Uck1 a useful node for pathway-focused mechanistic studies.
UCK1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Uck1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Uck1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Uck1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish UCK1 protein expression.
This CRISPR knockout system enables efficient generation of Uck1-deficient cell models for investigation of UCK1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.